Sangui BioTech International, Inc. ("SGBI") is a holding company the shares of which are being traded on the OTCQB marketplace and the OTC markets of the Berlin and Hamburg-Hannover stock exchanges. Its purpose is to provide financing and access to the capital markets for the enterprises of the Sangui group. SGBI has been a reporting company since 2000 and is current in its filings with the SEC.
Our_business case_in_a_nutshell (PDF file 4.7 MB)
Now available: Wound Market Research by Panaceus
(also available in German language)